MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-11-2026
Country |
 USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
382 M |
Market Cap[1] |
$ 113 B |
EBITDA (LTM) |
$ 5.7 B |
P/E (LTM) |
37.25 |
P/S (LTM) |
5.14 |
EPS (LTM) |
8.46 |
Stryker Corporation is an international company specializing in the production of medical equipment and instruments for surgery. The company was founded in 1941 in the United States and has since become one of the leaders in its field.
Stryker Corporation offers a wide range of products, including implants for orthopedics, neurosurgery, traumatology, and other areas of medicine, as well as tools for surgical operations and rehabilitation equipment.
The company is actively developing and expanding its business around the world. Today, SYK has offices in more than 100 countries and holds leading positions in the medical equipment market.
One of the company's main goals is to create innovative products that will help improve the quality of life for patients and facilitate the work of medical professionals. Stryker Corporation also actively works on improving its technologies and processes to ensure high-quality products and maximum safety for patients.
Stryker Corporation is an example of a successful business that combines innovation, quality, and responsibility to patients.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
$ 13.17 | 0.46 % | $ 1.78 B | Nasdaq Capital Market | USA |
 |
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | USA |
 |
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market |  China |
 |
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | USA |
 |
Delcath Systems
DCTH
|
$ 10.8 | 4.05 % | $ 387 M | Nasdaq Capital Market | USA |
 |
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | USA |
 |
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | USA |
 |
Electromed
ELMD
|
$ 25.6 | -0.43 % | $ 216 M | NYSE American | USA |
 |
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | USA |
 |
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | USA |
 |
EDAP TMS S.A.
EDAP
|
$ 3.47 | 4.52 % | $ 130 M | Nasdaq Global Market |  France |
 |
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | USA |
 |
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | USA |
 |
Helius Medical Technologies
HSDT
|
$ 2.12 | 3.92 % | $ 1.29 M | Nasdaq Capital Market | USA |
 |
Inspire Medical Systems
INSP
|
$ 56.7 | 1.0 % | $ 1.67 B | NYSE,SPB | USA |
 |
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | USA |
 |
LivaNova PLC
LIVN
|
$ 61.0 | 1.5 % | $ 3.33 B | Nasdaq Global Select Market |  Britain |
 |
ClearPoint Neuro
CLPT
|
$ 11.37 | 1.7 % | $ 322 M | Nasdaq Capital Market | USA |
 |
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | USA |
 |
Cytosorbents Corporation
CTSO
|
$ 0.61 | 0.36 % | $ 38 M | Nasdaq Capital Market | USA |
 |
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | USA |
 |
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | USA |
 |
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | USA |
 |
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | USA |
 |
IRIDEX Corporation
IRIX
|
$ 1.03 | - | $ 17.4 M | Nasdaq Global Select Market | USA |
 |
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market |  Israel |
 |
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | USA |
 |
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | USA |
 |
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
$ 15.65 | 3.92 % | $ 367 M | Nasdaq Global Select Market,SPB | USA |
 |
Butterfly Network
BFLY
|
$ 5.4 | 12.97 % | $ 1.14 B | NYSE | USA |
 |
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | USA |
 |
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | USA |
 |
Sintx Technologies
SINT
|
$ 2.41 | 14.22 % | $ 6.68 M | Nasdaq Capital Market | USA |
 |
Globus Medical
GMED
|
$ 91.34 | 1.29 % | $ 12.4 B | NYSE,SPB | USA |
 |
TransMedics Group
TMDX
|
$ 100.01 | -0.77 % | $ 3.4 B | Nasdaq Global Market | USA |
 |
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | USA |
 |
CONMED Corporation
CNMD
|
$ 36.8 | 0.38 % | $ 1.14 B | NYSE,SPB | USA |
 |
Integer Holdings Corporation
ITGR
|
$ 84.03 | -5.06 % | $ 2.92 B | NYSE,SPB | USA |
 |
Edwards Lifesciences Corporation
EW
|
$ 83.98 | 0.57 % | $ 49.1 B | NYSE,SPB | USA |
 |
Tandem Diabetes Care
TNDM
|
$ 19.41 | -0.61 % | $ 1.32 B | Nasdaq Global Market,SPB | USA |
 |
LENSAR
LNSR
|
$ 5.61 | 7.27 % | $ 67.1 M | Nasdaq Capital Market | USA |
 |
Pulmonx Corporation
LUNG
|
$ 1.35 | 5.47 % | $ 54.9 M | Nasdaq Global Select Market | USA |
 |
MiMedx Group
MDXG
|
$ 3.68 | 9.52 % | $ 544 M | Nasdaq Global Select Market | USA |
 |
Myomo
MYO
|
$ 0.9 | 4.16 % | $ 37.7 M | NYSE American | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.